Back
Smith-Midland Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
50
SMID
Smith-Midland
Last Price:
$38.80
Seasonality Move:
2.52%
Sell
37
ASND
Ascendis Pharma AS
Last Price:
$131.63
Seasonality Move:
10.85%
Sell
50
Smith-Midland (SMID)
is a Sell
Is Smith-Midland a Buy, Sell or Hold?
-
The current Smith-Midland [SMID] share price is $39.43. The Score for SMID is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SMID is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $131.57. The Score for ASND is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SMID Stock Price Chart
What is Smith-Midland's stock price today?
-
The Smith-Midland share price today is $39.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMID is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $131.57Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
SMID Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.26 | Sell |
Relative Strength Index (14 RSI): | 37.98 | Sell |
Chaikin Money Flow: | 18596 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.31 - 47.69) | Sell |
Bollinger Bands (100): | (32.33 - 44.19) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 44.98 | Sell |
Chaikin Money Flow: | -344685 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.17 - 139.23) | Sell |
Bollinger Bands (100): | (124.64 - 141.54) | Sell |
SMID Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.09 | Sell |
20-day SMA: | 43.48 | Sell |
50-day SMA: | 42.97 | Sell |
200-day SMA: | 36.42 | Buy |
8-day EMA: | 40.76 | Sell |
20-day EMA: | 42.66 | Sell |
50-day EMA: | 42.08 | Sell |
200-day EMA: | 37.03 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 135.65 | Sell |
20-day SMA: | 136.62 | Sell |
50-day SMA: | 131.93 | Sell |
200-day SMA: | 134.44 | Sell |
8-day EMA: | 134.46 | Sell |
20-day EMA: | 135.22 | Sell |
50-day EMA: | 133.88 | Sell |
200-day EMA: | 131.63 | Sell |
Smith-Midland Earnings Growth & SMID Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.44 per share, and an increase next year of $5.94 per share.
Smith-Midland Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |